MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
出版年份 2016 全文链接
标题
MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 49, Pages 6330-6340
出版商
Springer Nature
发表日期
2016-06-06
DOI
10.1038/onc.2016.164
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer
- (2015) Jing Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death
- (2015) Lei Wang et al. CANCER CELL
- Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells
- (2015) Motoshi Suzuki et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP
- (2015) Xin Zhang et al. MOLECULAR CELL
- Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells
- (2015) Jin-Man Kim et al. NUCLEIC ACIDS RESEARCH
- CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
- (2015) Ariane Hammitzsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer
- (2015) Moloy T. Goswami et al. Oncotarget
- Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes
- (2015) Artem G. Lada et al. PLoS Genetics
- Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
- (2015) Fang Zheng et al. PLoS Genetics
- A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress
- (2015) Jong Woo Lee et al. PLoS One
- The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression
- (2015) Balabhadrapatruni V. S. K. Chakravarthi et al. Oncotarget
- Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
- (2015) Rui Wang et al. NEOPLASIA
- Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells
- (2014) J Bargiela-Iparraguirre et al. CELL CYCLE
- Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma
- (2014) Lei Chen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
- (2014) B T Gjertsen et al. LEUKEMIA
- TCGA-Assembler: open-source software for retrieving and processing TCGA data
- (2014) Yitan Zhu et al. NATURE METHODS
- Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation
- (2014) F Yan et al. Cell Death & Disease
- Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining
- (2014) D Qian et al. Cell Death & Disease
- Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma
- (2013) J A Pezuk et al. CANCER GENE THERAPY
- Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors
- (2013) Michel D. Wissing et al. FASEB JOURNAL
- Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
- (2013) P. G. Ferreira et al. GENOME RESEARCH
- c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
- (2013) Lei Wang et al. HEPATOLOGY
- Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer
- (2012) Y Peng et al. CANCER GENE THERAPY
- MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1
- (2012) Rui Wang et al. PLoS One
- MYC and Metastasis
- (2011) A. Wolfer et al. CANCER RESEARCH
- MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance
- (2011) Liang Luo et al. MEDICAL ONCOLOGY
- Sub1 and RPA Associate with RNA Polymerase II at Different Stages of Transcription
- (2011) Timothy W. Sikorski et al. MOLECULAR CELL
- FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway
- (2011) Filippos Kottakis et al. MOLECULAR CELL
- Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays
- (2010) Benjamin Chain et al. BMC BIOINFORMATICS
- Human Positive Coactivator 4 Controls Heterochromatinization and Silencing of Neural Gene Expression by Interacting with REST/NRSF and CoREST
- (2010) Chandrima Das et al. JOURNAL OF MOLECULAR BIOLOGY
- Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
- (2010) Nallasivam Palanisamy et al. NATURE MEDICINE
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Sub1/PC4 a chromatin associated protein with multiple functions in transcription
- (2010) Christine Conesa et al. RNA Biology
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
- (2009) D. Rudolph et al. CLINICAL CANCER RESEARCH
- DIANA-microT web server: elucidating microRNA functions through target prediction
- (2009) M. Maragkakis et al. NUCLEIC ACIDS RESEARCH
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started